Skip to content

Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data

Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00880256
Enrollment
93
Registered
2009-04-13
Start date
2008-09-30
Completion date
2010-10-31
Last updated
2012-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

irritable bowel, mindfulness, stress, meditation

Brief summary

Irritable bowel syndrome (IBS) is a very common, chronic disorder that significantly affects quality of life, and results in enormous expenditures each year in the United States. Therapy for IBS is generally unsatisfactory, and takes an additive approach whereby medications are prescribed according to each type of symptom the patient experiences. Accumulating evidence indicates that persons with IBS have a heightened perception of stress, and chronic stress has been shown to have a significant impact on IBS symptomatology. Mindfulness involves the ability to bring attention to the present moment without judgment; this ability is correlated with measures of mental health and decreased stress perception. The clinical literature suggests that mindfulness-based interventions may lead to improvement in many disorders including chronic pain, stress, anxiety, eating disorders and depressive relapse. The purpose of this study is to collect survey pilot data to determine whether an 8-week program of mindfulness-based stress reduction (MBSR) improves symptoms and quality of life for persons with IBS. Patients in the 8-week MBSR program are referred as part of their clinical care, and we seek approval only to collect survey data before and after the MBSR course. This study will evaluate whether there is sufficient evidence of efficacy to warrant a full clinical trial of MBSR.

Detailed description

Aim 1: Apply measures of IBS symptom severity, depression and quality of life before and after the MBSR course, to assess whether there is evidence of benefit, and allow calculation of standardized effect sizes. Aim 2: Apply a validated measure of mindfulness before and after treatment. Aim 3: Explore the relationship between IBS symptoms, mindfulness score, and frequency of mindfulness practice.

Interventions

BEHAVIORALmindfulness-based stress reduction

An 8-week course in mindfulness training

Sponsors

Seattle Institute for Biomedical and Clinical Research
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patient who enroll in a MBSR course

Exclusion criteria

* Psychosis, borderline personality, active substance abuse

Design outcomes

Primary

MeasureTime frameDescription
IBS (Irritable Bowel Syndrome) Symptom Severity Score (Total Score)6 monthsThe Irritable Bowel Severity Scoring System (IBSSS) provides a measure of the severity of IBS. The measure consists of five questions, which assess severity of abdominal pain, number of days with abdominal pain in past 10 days, severity of abdominal distension, satisfaction with bowel habits, and impact of IBS on life in general. The score on each of the 5 questions ranges from 0 to 100, and the scores are summed with a range of total possible scores from 0 to 500. Higher scores reflect more severe IBS. Total score was used in the analyses.

Secondary

MeasureTime frameDescription
Irritable Bowel Syndrome (IBS) Quality of Life6 monthsThe IBS-QOL is a disease specific Quality-of-Life Measure for IBS. IBS-QOL has been shown have a high level of content validity and to be responsive to change, and has been used in several outcome studies and clinical drug trials throughout the world. It consists of 34 questions that assess the influence of bowel habits on daily life. The response to each question is rated on a 5-point scale. A lower score indicates worse bowel-related quality of life. The summed total score is transformed to a 0-100 scale ranging from 0 (poor quality of life) to 100 (maximum quality of life).

Countries

United States

Participant flow

Recruitment details

During a 17-month period, we enrolled 93 patients who were referred or self-referred themselves to the Mindfulness-Based Stress Reduction (MBSR) program at VA Puget Sound.

Participants by arm

ArmCount
MBSR
Patients who undergo mindfulness-based stress reduction will fill out measures of IBS severity before and after the mindfulness course.
93
Total93

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up28

Baseline characteristics

CharacteristicMBSR
Age Continuous51 years
STANDARD_DEVIATION 10.6
Sex: Female, Male
Female
24 Participants
Sex: Female, Male
Male
69 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 93
serious
Total, serious adverse events
0 / 93

Outcome results

Primary

IBS (Irritable Bowel Syndrome) Symptom Severity Score (Total Score)

The Irritable Bowel Severity Scoring System (IBSSS) provides a measure of the severity of IBS. The measure consists of five questions, which assess severity of abdominal pain, number of days with abdominal pain in past 10 days, severity of abdominal distension, satisfaction with bowel habits, and impact of IBS on life in general. The score on each of the 5 questions ranges from 0 to 100, and the scores are summed with a range of total possible scores from 0 to 500. Higher scores reflect more severe IBS. Total score was used in the analyses.

Time frame: 6 months

Population: We compared scores at baseline, 2-month, and 6-month time points, using t-tests. A two-sided P value of less than 0.05 was considered statistically significant. The standardized mean difference (Cohen's d effect size) from baseline to 2-months, and baseline to 6-months was calculated for each variable.

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-Based Stress Reduction (MBSR)IBS (Irritable Bowel Syndrome) Symptom Severity Score (Total Score)IBS (IBS) symptoms256.9 units on a scaleStandard Deviation 90.6
Mindfulness-Based Stress Reduction (MBSR)IBS (Irritable Bowel Syndrome) Symptom Severity Score (Total Score)Irritable Bowel Syndrome Quality of LIfe (QOL)84.4 units on a scaleStandard Deviation 20.6
Secondary

Irritable Bowel Syndrome (IBS) Quality of Life

The IBS-QOL is a disease specific Quality-of-Life Measure for IBS. IBS-QOL has been shown have a high level of content validity and to be responsive to change, and has been used in several outcome studies and clinical drug trials throughout the world. It consists of 34 questions that assess the influence of bowel habits on daily life. The response to each question is rated on a 5-point scale. A lower score indicates worse bowel-related quality of life. The summed total score is transformed to a 0-100 scale ranging from 0 (poor quality of life) to 100 (maximum quality of life).

Time frame: 6 months

Population: All participants who completed at 6 months were included

ArmMeasureValue (MEAN)Dispersion
Mindfulness-Based Stress Reduction (MBSR)Irritable Bowel Syndrome (IBS) Quality of Life224.3 units on a scaleStandard Deviation 96.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026